Securities code: 000756 securities abbreviation: Shandong Xinhua Pharmaceutical Company Limited(000756) Announcement No.: 2021-82 Shandong Xinhua Pharmaceutical Company Limited(000756)
Announcement on resolutions of the seventh extraordinary meeting of the 10th board of directors in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shandong Xinhua Pharmaceutical Company Limited(000756) (“the company” or “the company”) the notice of the seventh extraordinary meeting of the 10th board of directors in 2021 was sent by e-mail on December 29, 2021, and the meeting was held by written signature on December 31, 2021. There are 8 directors who should attend the meeting and 8 actually attended the meeting. The convening of the meeting shall comply with the provisions of relevant laws, regulations, rules and the articles of association.
The meeting considered and passed the following proposals and formed the following resolutions:
1、 The proposal on granting 2021 A-share stock options to incentive objects for the first time was reviewed and passed
In accordance with the measures for the administration of equity incentive of listed companies, the relevant provisions of the company’s 2021 A-share stock option incentive plan (Draft), and the authorization of the company’s first extraordinary general meeting in 2021, the second A-share general meeting in 2021 and the second H-share general meeting in 2021, The board of directors of the company considers that the grant conditions specified in the A-share stock option incentive plan of the company in 2021 have been met, and agrees to grant 23.15 million stock options to 196 eligible incentive objects with December 31, 2021 as the first grant date.
Voting results: Zhang Daiming, he Tongqing, Du Deping and Xu lie, the related directors, avoided voting, and 4 agreed, accounting for 100% of the number of unrelated directors of the company; 0 against and 0 abstention.
The announcement on the first granting of 2021 A-share stock options to incentive objects and the independent opinions of independent directors on this proposal are published on cninfo.com on the same day（ http://www.cn.info.com..cn. ）Relevant announcements. Documents for future reference
1. Resolutions of the seventh extraordinary meeting of the 10th board of directors in 2021;
2. Independent opinions of independent directors on matters related to the seventh extraordinary meeting of the 10th board of directors in 2021.
It is hereby announced.
Shandong Xinhua Pharmaceutical Company Limited(000756) board of directors
December 31, 2021
